RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Steele Foundation for Hope
S

Steele Foundation for Hope portfolio

Steele Foundation for Hope has 1 portfolio company on record at Recent Funding.

Type: Foundation.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 2 of 2.
Capital in their rounds: $63M.
Latest deal: Sibel Health · Mar 20, 2025.
About this page

It is a foundation, founded in 2022. It led 2 of the 2 rounds it joined. Its most recent investment on record is Sibel Health's $30M Series B+ round in March 2025, which it led, alongside Dräger. That company is in Health and bio. It has co-invested with Dräger.

About Steele Foundation for Hope

Firm type: Foundation.
Founded: 2022.
Sectors: AgTech, AI & Machine Learning, Biotech, Cleantech, Digital Health, EdTech, FoodTech, Healthtech, Impact & Social Good, Medical Devices.
Leads rounds: Yes.
Portfolio companies: 25.
Exits: 0.
Rounds led: 2.

What Steele Foundation for Hope invests in

How Steele Foundation for Hope invests

StageDealsCapital in rounds
Series B+ 2 100%$63M
YearDealsCapital in rounds
2022 1 50%$33M
2025 1 50%$30M

Steele Foundation for Hope portfolio companies

CompanyRound with Steele Foundation for HopeTotal raisedLatest raise
SSibel Health
Health and bio
Series B+ · $30M · lead$63MOct 14, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name Steele Foundation for Hope. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Steele Foundation for Hope, which is a subset of its real portfolio. API: /api/v1/investors/steele-foundation-for-hope (get a free API key). More: the most active VC firms and new venture capital funds.